13F
中

TMDX TRANSMEDICS GROUP INC

2026Q1 · CUSIP 89377M109 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
411
Δ holders QoQ
-15
Breadth percentile
Top 90%
Whale holders
174
Δ whales
0
Inst. holding value
$3.6B
New positions
68
Closed positions
83
Price momentum (1Q)
-48.9%
Put / Call
9/9

Breadth history (34 quarters)

2019Q3: Δ-17 · h=48 2019Q4: Δ+13 · h=61 2020Q1: Δ-7 · h=54 2020Q2: Δ+15 · h=69 2020Q3: Δ+3 · h=72 2020Q4: Δ-2 · h=70 2021Q1: Δ+36 · h=106 2021Q2: Δ+18 · h=124 2021Q3: Δ-4 · h=120 2021Q4: Δ+1 · h=121 2022Q1: Δ-13 · h=108 2022Q2: Δ+26 · h=134 2022Q3: Δ+45 · h=179 2022Q4: Δ+22 · h=201 2023Q1: Δ+19 · h=220 2023Q2: Δ+20 · h=240 2023Q3: Δ-19 · h=221 2023Q4: Δ+27 · h=248 2024Q1: Δ+15 · h=263 2024Q2: Δ+73 · h=336 2024Q3: Δ+35 · h=371 2024Q4: Δ-59 · h=312 2025Q1: Δ-18 · h=294 2025Q2: Δ+71 · h=365 2025Q3: Δ+20 · h=385 2025Q4: Δ+41 · h=426 2026Q1: Δ-15 · h=411 2019Q3: holders=48 2019Q4: holders=61 2020Q1: holders=54 2020Q2: holders=69 2020Q3: holders=72 2020Q4: holders=70 2021Q1: holders=106 2021Q2: holders=124 2021Q3: holders=120 2021Q4: holders=121 2022Q1: holders=108 2022Q2: holders=134 2022Q3: holders=179 2022Q4: holders=201 2023Q1: holders=220 2023Q2: holders=240 2023Q3: holders=221 2023Q4: holders=248 2024Q1: holders=263 2024Q2: holders=336 2024Q3: holders=371 2024Q4: holders=312 2025Q1: holders=294 2025Q2: holders=365 2025Q3: holders=385 2025Q4: holders=426 2026Q1: holders=411 -73 -36.5 +0 +36.5 +73 43246448 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 14 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 13% -48.9% —
2025Q3 Top 16% +17.2% -40.0%
2025Q2 Top 3% -8.5% +7.8%
2024Q3 Top 7% -11.1% +52.4%
2024Q2 Top 1% -48.1% -53.4%
2024Q1 Top 19% +21.1% -41.7%
2023Q4 Top 20% +53.4% +85.8%
2023Q2 Top 10% +2.1% +41.0%

Options Sentiment

Put holders
9
QoQ: 0
Call holders
9
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
17.1
EPS (TTM)
$4.37
EPS YoY
+221.3%
Revenue (TTM)
$0.6B
Revenue YoY
+30.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $21M 2022-09-30: $26M 2022-12-31: $31M 2023-03-31: $42M 2023-06-30: $52M 2023-09-30: $66M 2023-12-31: $81M 2024-03-31: $97M 2024-06-30: $114M 2024-09-30: $109M 2024-12-31: $122M 2025-03-31: $144M 2025-06-30: $157M 2025-09-30: $144M 2025-12-31: $161M 2026-03-31: $174M 2022-06-30: EPS -0.41 2022-09-30: EPS -0.25 2022-12-31: EPS -0.19 2023-03-31: EPS -0.08 2023-06-30: EPS -0.03 2023-09-30: EPS -0.78 2023-12-31: EPS 0.12 2024-03-31: EPS 0.35 2024-06-30: EPS 0.35 2024-09-30: EPS 0.12 2024-12-31: EPS 0.19 2025-03-31: EPS 0.70 2025-06-30: EPS 0.92 2025-09-30: EPS 0.66 2025-12-31: EPS 2.59 2026-03-31: EPS 0.20 0M 87M 174M $M -0.86 1.00 2.85 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 72 2024-06-30: PE 42572024-09-30: PE 85.62024-12-31: PE 71.52025-03-31: PE 89.42025-06-30: PE 66.12025-09-30: PE 46.62025-12-31: PE 26.72026-03-31: PE 14.5 13 2241 4470 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)